Form 4: Arcutis Director Gifts Shares to Charitable Trust
Insider Transaction Report
Arcutis Biotherapeutics Director Keith R. Leonard reported gifting 4,312 shares of common stock to a Charitable Remainder Unitrust.
Summary
- Keith R. Leonard, a Director of Arcutis Biotherapeutics, Inc., reported a transaction involving the company's common stock.
- On November 13, 2025, Leonard gifted 4,312 shares of common stock to a Charitable Remainder Unitrust.
- The transaction price for the gifted shares was $0.
- Following this transaction, Leonard directly beneficially owns 22,123 shares of common stock.
- Additionally, 1,750 shares are indirectly beneficially owned through the Leonard Family Trust dated August 28, 1996, for which Leonard is a trustee.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction involving a gift of shares by a director to a charitable trust, which is a personal financial planning event and does not inherently reflect positively or negatively on the company's operational performance or future prospects.
Future Outlook
NA
Industry Context
NA
Key Dates
| Date | Description |
|---|---|
| 11/13/2025 | Date of transaction where shares were gifted. |
| 11/17/2025 | Date the Form 4 was signed and filed. |
Recommendation
holdThe filing details a director's personal gift of shares to a charitable trust, which is a routine insider transaction and does not provide new information regarding the company's financial performance, strategic direction, or operational health. Therefore, it does not warrant a change in investment recommendation based solely on this report.
Keywords
Arcutis Biotherapeutics, ARQT, Form 4, insider transaction, stock gift, director, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.